These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1509994)

  • 1. Long-term follow-up of patients with inducible supraventricular tachycardia treated with flecainide or propafenone: therapy guided by transesophageal electropharmacologic testing.
    Furlanello F; Guarnerio M; Inama G; Vergara G; Del Greco M; Bertoldi A; Dallago M
    Am J Cardiol; 1992 Aug; 70(5):19A-25A. PubMed ID: 1509994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Electropharmacological test with class-I C drugs in paroxysmal supraventricular re-entrant tachycardia: is a negative result with a drug predictive of the ineffectiveness of other drugs of the same class?].
    Inama G; Furlanello F; Braito G; Guarnerio M; Vergara G
    G Ital Cardiol; 1991 Feb; 21(2):131-8. PubMed ID: 1907937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M; Cullen MT; Casadei G
    Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite effects of propafenone and flecainide in a patient with reciprocating supraventricular tachycardia.
    Montenero AS; Natale A; di Bona G; Calvi V; Santarelli P; Manzoli U
    Cardiologia; 1990 Mar; 35(3):253-6. PubMed ID: 2123130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flecainide acetate in the treatment of supraventricular tachycardias: value of programmed electrical stimulation for long-term prognosis.
    van Wijk LM; Crijns HJ; van Gilst WH; Wesseling H; Lie KI
    Am Heart J; 1989 Feb; 117(2):365-9. PubMed ID: 2492738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The pharmacological treatment of supraventricular atrioventricular nodal reentry or accessory pathway reentry tachycardias: the usefulness of transesophageal electrophysiological study in the selection of therapy].
    Sarubbi B; Ducceschi V; Esposito R; Briglia N; Manzo G; Mayer MS; Santangelo L; Iacono A
    Cardiologia; 1996 Jun; 41(6):543-9. PubMed ID: 8766417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardia.
    Hammill SC; McLaran CJ; Wood DL; Osborn MJ; Gersh BJ; Holmes DR
    J Am Coll Cardiol; 1987 Jun; 9(6):1364-8. PubMed ID: 3584724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flecainide single oral dose for management of paroxysmal supraventricular tachycardia in children and young adults.
    Musto B; Cavallaro C; Musto A; D'Onofrio A; Belli A; De Vincentis L
    Am Heart J; 1992 Jul; 124(1):110-5. PubMed ID: 1615792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular tachycardia.
    Musto B; D'Onofrio A; Cavallaro C; Musto A
    Circulation; 1988 Oct; 78(4):863-9. PubMed ID: 3168194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of intravenous propafenone and flecainide in the treatment of tachycardias associated with the Wolff-Parkinson-White syndrome.
    O'Nunain S; Garratt CJ; Linker NJ; Gill J; Ward DE; Camm AJ
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):2028-34. PubMed ID: 1721219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous flecainide acetate for supraventricular tachycardias.
    Hellestrand KJ
    Am J Cardiol; 1988 Aug; 62(6):16D-22D. PubMed ID: 3136630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current treatment options for paroxysmal supraventricular tachycardia.
    Mannino MM; Mehta D; Gomes JA
    Am Heart J; 1994 Feb; 127(2):475-80. PubMed ID: 8296727
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term efficacy and safety of flecainide for supraventricular tachycardia.
    Neuss H; Schlepper M
    Am J Cardiol; 1988 Aug; 62(6):56D-61D. PubMed ID: 3136637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia.
    Hoff PI; Tronstad A; Oie B; Ohm OJ
    Am J Cardiol; 1988 Sep; 62(9):585-9. PubMed ID: 3137798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The study of acute clinical electrophysiological effects of propafenone on paroxysmal supraventricular tachycardia using transesophageal atrial pacing technique].
    Li Q; Wang Z; Peng D
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(2):123-6. PubMed ID: 9868052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias.
    Hohnloser SH; Zabel M
    Am J Cardiol; 1992 Aug; 70(5):3A-9A; discussion 9A-10A. PubMed ID: 1387287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia.
    Musto B; D'Onofrio A; Cavallaro C; Musto A; Greco R
    Am J Cardiol; 1988 Aug; 62(4):229-33. PubMed ID: 3135739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxysmal supraventricular tachycardia: experience with propafenone.
    Santinelli V; De Paola M; Turco P; Smimmo D; Chiariello M
    Angiology; 1989 Jun; 40(6):563-8. PubMed ID: 2719341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of transesophageal electrophysiological study during the ergometric test in the evaluation of supraventricular paroxysmal tachycardia occurring during exertion].
    Delise P; D'Este D; Bonso A; Allibardi P; Raviele A; Di Pede F; Piccolo E
    G Ital Cardiol; 1989 Dec; 19(12):1094-104. PubMed ID: 2576799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tachycardias: considerations in childhood in the 90s].
    Gutiérrez-Larraya F; Jabón A
    An Esp Pediatr; 1993 Dec; 39(6):475-88. PubMed ID: 8166400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.